Abstract
A series of new, halogen containing N-substituted 4-aminobenzenesulfonamides were synthesized by using superacid HF/SbF5 chemistry and investigated as inhibitors of several human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms, that is, the cytosolic hCA I and II and, the tumor-associated transmembrane isoforms hCA IX and XII. Despite the substitution of the sulfonamide function, the presence of fluorine atom(s) in β position of the sulfonamide function strongly favors hCA inhibition. A similar effect of the β-fluorinated alkyl substitution on the amino function has been also observed. Among the tested compounds, several chlorinated derivatives have been identified as selective nanomolar, tumor-associated isoforms inhibitors. These non-primary sulfonamides probably bind in the coumarin-binding site, at the entrance of the cavity, and not to the metal ion as the primary sulfonamide inhibitors.
Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, Neoplasm / chemistry*
-
Antigens, Neoplasm / metabolism
-
Binding Sites
-
Carbonic Anhydrase I / chemistry
-
Carbonic Anhydrase I / metabolism
-
Carbonic Anhydrase II / chemistry
-
Carbonic Anhydrase II / metabolism
-
Carbonic Anhydrase IX
-
Carbonic Anhydrase Inhibitors / chemical synthesis*
-
Carbonic Anhydrase Inhibitors / chemistry
-
Carbonic Anhydrase Inhibitors / metabolism
-
Carbonic Anhydrases / chemistry*
-
Carbonic Anhydrases / metabolism
-
Catalytic Domain
-
Fluorine / chemistry*
-
Humans
-
Molecular Docking Simulation
-
Neoplasms / enzymology
-
Neoplasms / metabolism
-
Neoplasms / pathology
-
Protein Binding
-
Structure-Activity Relationship
-
Sulfonamides / chemical synthesis
-
Sulfonamides / chemistry*
-
Sulfonamides / metabolism
Substances
-
Antigens, Neoplasm
-
Carbonic Anhydrase Inhibitors
-
Sulfonamides
-
Fluorine
-
Carbonic Anhydrase I
-
Carbonic Anhydrase II
-
CA9 protein, human
-
Carbonic Anhydrase IX
-
Carbonic Anhydrases
-
carbonic anhydrase XII